Ernexa Therapeutics Inc.: Form 8-K, filed Jun 11, 2013
Filed with the SEC on Jun 11, 2013 and accepted by EDGAR at Jun 11, 2013, 17:26 ET.
Items reported
- Item 5.03 Amendment to articles or bylaws
- Item 5.07 Shareholder vote results
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001019687-13-002314. Last ingested by Listed: Nov 11, 2026, 02:49 ET. Listed shows no prices and gives no investment advice.